Inside Penn

In brief, what’s happening at Penn—whether it’s across campus or around the world.

Filter Stories

Displaying 1491 - 1500 of 2520

  • Consumer disappointment with retailers runs deep

    A new Wharton Baker WisePlum Consumer Loyalty Study reveals that consumers are less forgiving, and need more from retailers during the global pandemic.

    FULL STORY AT Wharton →

  • Tackling the bioethics challenges raised by COVID-19

    In an editorial in the journal AJOB Empirical Bioethics, three nurse researchers provide ideas for meaningful empirical bioethics research related to the COVID-19 pandemic to aid clinicians in ethical decision-making approaches.

    FULL STORY AT Penn Nursing News →

  • Achieving better postpartum care

    A new study published in Medical Care examines the health care use of nearly 600,000 mother-infant pairs who were eligible for Medicaid for at least 11 of the 12 months following birth in 12 geographically diverse states. They found that 38% of mothers on Medicaid had no adult preventive visits one year postpartum.

    FULL STORY AT Leonard Davis Institute →

  • Big ideas for strange times

    Penn Arts & Sciences’ newest series of faculty talks created during the COVID-19 pandemic feed the need to engage with ideas that transcend the immediate crisis. In Big Ideas for Strange Times, professors to ponder some of life’s bigger questions in short virtual lectures. 

    FULL STORY AT OMNIA →

  • Introducing the Green New Deal Superstudio

    The Ian L. McHarg Center for Urbanism and Ecology at the Weitzman School of Design is partnering with The Landscape Architecture Foundation, the Center for Resilient Cities and Landscapes, the American Society of Landscape Architects, and the Council of Educators in Landscape Architecture to launch The Green New Deal Superstudio, an open call for designs that spatially manifest the principles and policy ideas of the Green New Deal with regional and local specificity.

    FULL STORY AT Weitzman School of Design →

  • Paul Robinson elected to American Law Institute

    After a 15-year hiatus, University of Pennsylvania Carey Law School’s Colin S. Diver Professor of Law Paul Robinson was reelected as a member of the American Law Institute (ALI) in June. Founded in 1923, the ALI is an independent organization that produces scholarly work to clarify, modernize, and improve the law. Its elected members include eminent lawyers, judges, and academics.

    FULL STORY AT Penn Carey Law →

  • Jennifer Pinto-Martin named University Ombuds

    Jennifer A. Pinto-Martin, Viola MacInnes/Independence Professor of Nursing and Executive Director of the Center for Public Health Initiatives in the School of Nursing and Professor of Epidemiology in the Perelman School of Medicine, has agreed to serve as University Ombuds, beginning on July 1, 2020 for a two-year term. Pinto-Martin succeeds Lynn Hollen Lees.

    FULL STORY AT Almanac →

  • Cancer care in the time of COVID

    Don’t delay your medical care. It sounds like common sense, but in the era of COVID-19, people who normally wouldn’t hesitate to call a doctor when something doesn’t feel right, might avoid doing so out of concern about any kind of post-lockdown activity. But the medical community is urgently trying to advise the public that seeking health care is still essential. It’s particularly complicated in cancer care, where early detection is key.

    FULL STORY AT Penn Medicine News →

  • A new model for research review aims to address quality challenges

    Senators Elizabeth Warren, Bernie Sanders, and Sherrod Brown recently raised concerns about the increasing use of for-profit Institutional Review Boards (IRBs) to review research proposals, as opposed to boards typically housed at academic medical centers and health care institutions. A new paper highlights inherent challenges facing IRBs of all types and especially private equity-owned boards.

    FULL STORY AT Penn Medicine News →

  • Hepatitis C and the layering of disease-related stigma

    In the U.S., hepatitis C virus (HCV) infection affects nearly 4.5 million people, is the leading cause of chronic liver disease, and was the leading cause of infectious disease-related deaths prior to the COVID-19 pandemic. Patients with HCV face significant stigma associated with their diagnosis, but the prevalence and determinants of this stigma have not been examined. In a recent study, researchers explore demographic, clinical, and behavioral factors associated with patients’ experiences of HCV-related stigma.

    FULL STORY AT Leonard Davis Institute →